A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension

Status:
Completed

Trial end date:
2005-06-01

Target enrollment:

Participant gender:

A ONE YEAR SAFETY STUDY FOR PATIENTS WHO COMPLETE STUDY VAA489A2307.

Phase 3

Novartis

Amlodipine
Valsartan